Evaluating Treatment Effect in Multicenter Trials with Small Centers Using Survival Modeling
DOI:
https://doi.org/10.6000/1929-6029.2015.04.01.2Keywords:
Frailty, survival, clinical trial, prognostic factor, rare disease.Abstract
Clinical trials of rare diseases commonly enlist several centers to achieve recruitment goals. The aim of this study is to examine the estimation of treatment effects for survival outcomes in multicenter clinical trials with varying numbers of centers and few patients per center for rarer disease outcomes (i.e. rare cancers). We modeled the heterogeneity between centers using Cox frailty models to account for the variability in patients and patient care between centers and examined measures of model fit via smoothed functions of a prognostic factor. Through a simulation study, we were able to examine the consequence of having only a few centers or a few patients per center on the treatment and prognostic factor effects and model performance indices. Overall, we found it is preferable to have more patients per site and more sites in a multicenter trial as expected. However, having a few patients per site is feasible if there are many sites in a trial.
References
Matthews JN. Small clinical trials: are they all bad? Statist Med 1995; 14(2): 115-126. http://dx.doi.org/10.1002/sim.4780140204 DOI: https://doi.org/10.1002/sim.4780140204
Localio A, Berlin J, Ten Have T, Kimmel S. Adjustments for center in multicenter studies: An overview. Ann Inter Med 2007; 135(2): 112-123. http://dx.doi.org/10.7326/0003-4819-135-2-200107170-00012 DOI: https://doi.org/10.7326/0003-4819-135-2-200107170-00012
Ambler G, Seaman S, Omar RZ. An evaluation of penalised survival methods for developing prognostic models with rare events. Statist Med 2012; 31(11-12): 1150-1161. http://dx.doi.org/10.1002/sim.4371 DOI: https://doi.org/10.1002/sim.4371
Senn S. Planning and analyzing multi-centre trials. Statist Med 1998; 17: 1753-1765. http://dx.doi.org/10.1002/(SICI)1097-0258(19980815/30)17:15/16<1753::AID-SIM977>3.0.CO;2-X DOI: https://doi.org/10.1002/(SICI)1097-0258(19980815/30)17:15/16<1753::AID-SIM977>3.0.CO;2-X
Duchateau L, Janssen P, Lindsey P, Legrand C, Nguti R, Sylvester R. The shared frailty model and the power for heterogeneity tests in multicenter trials. Comput Statist Data Anal 2002; 40. DOI: https://doi.org/10.1016/S0167-9473(02)00057-9
Duchateau L, Janssen P. The frailty model. Vol New York 2008.
Jeong J-H, Costantino J. Application of smoothing methods to evaluate treatment-prognostic factor interactions in breast cancer data. Cancer Investig 2006; 24: 288-293. http://dx.doi.org/10.1080/07357900600633841 DOI: https://doi.org/10.1080/07357900600633841
Silverman BG, Siegelmann-Danieli N, Braunstein R, Kokia ES. Trends in breast cancer incidence associated with reductions in the use of hormone replacement therapy. Cancer Epidemiol 2011; 35(1): 11-16. DOI: https://doi.org/10.1016/j.canep.2010.11.006
Govindarajulu US, Malloy EJ, Ganguli B, Spiegelman D, Eisen EA. The comparison of alternative smoothing methods for fitting non-linear exposure-response relationships with Cox models in a simulation study. Int J Biostatist 2009; 5(1): Article 2. DOI: https://doi.org/10.2202/1557-4679.1104
Therneau T, Grambsch P. Modeling survival data: extending the Cox Model. New York: Springer-Verlag 2002.
Bender R, Augustin T, Blettner M. Generating survival times to simulate Cox proportional hazards models. Statist Med 2005; 24(11): 1713-1723. http://dx.doi.org/10.1002/sim.2059 DOI: https://doi.org/10.1002/sim.2059
Malloy EJ, Spiegelman D, Eisen EA. Comparing measures of model selection for penalized splines in Cox models. Comput Stat Data Anal 2009; 53(7): 2605-2616. http://dx.doi.org/10.1016/j.csda.2008.12.008 DOI: https://doi.org/10.1016/j.csda.2008.12.008
Klein J, Moeschberger M. Survival analysis: Techniques for censored and truncated data. New York: Springer 1997.
Armitage P, Doll R, (Ed) IJN. Stochastic models for carcinogenesis. Proceedings of the Fourth Berkeley Symposium on Mathematical Statistics and Probability; Berkeley (Univ. of California) 1961.
Breslow N, Day N. Statistical methods in cancer research: The design and analysis of cohort studies. Int Agency Res Cancer 1987; 2.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2015 Usha S. Govindarajulu, Elizabeth J. Malloy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Policy for Journals/Articles with Open Access
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work
Policy for Journals / Manuscript with Paid Access
Authors who publish with this journal agree to the following terms:
- Publisher retain copyright .
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work .
